A controlled-release nanocarrier with extracellular pH value driven tumor targeting and translocation for drug delivery.
about
Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment.Extracellularly activatable nanocarriers for drug delivery to tumors.Enhancement of radiation effect on cancer cells by gold-pHLIPSite-Specific Drug-Releasing Polypeptide Nanocarriers Based on Dual-pH Response for Enhanced Therapeutic Efficacy against Drug-Resistant Tumors.Residue-specific structures and membrane locations of pH-low insertion peptide by solid-state nuclear magnetic resonanceThe pH low insertion peptide pHLIP Variant 3 as a novel marker of acidic malignant lesionsStimuli-responsive nanoparticles for targeting the tumor microenvironment.Advanced targeted nanomedicineTransformable Peptide Nanocarriers for Expeditious Drug Release and Effective Cancer Therapy via Cancer-Associated Fibroblast Activation.Construction of A Triple-Stimuli-Responsive System Based on Cerium Oxide Coated Mesoporous Silica Nanoparticles.Smart Mesoporous Nanomaterials for Antitumor Therapy.Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery.Cell-specific aptamers and their conjugation with nanomaterials for targeted drug delivery.Advanced Functional Nanomaterials for Theranostics.A pH-dependent charge reversal peptide for cancer targeting.Versatile surface engineering of porous nanomaterials with bioinspired polyphenol coatings for targeted and controlled drug delivery.Inspired by nonenveloped viruses escaping from endo-lysosomes: a pH-sensitive polyurethane micelle for effective intracellular trafficking.A facile route to core-shell nanoparticulate formation of arsenic trioxide for effective solid tumor treatment.Advances in Peptide Functionalization on Mesoporous Silica Nanoparticles for Controlled Drug Release.Single-Vehicular Delivery of Antagomir and Small Molecules to Inhibit miR-122 Function in Hepatocellular Carcinoma Cells by using "Smart" Mesoporous Silica Nanoparticles.Noncanonical amino acids to improve the pH response of pHLIP insertion at tumor acidity.Functional nanovalves on protein-coated nanoparticles for in vitro and in vivo controlled drug delivery.Efficacious anticancer drug delivery mediated by a pH-sensitive self-assembly of a conserved tripeptide derived from tyrosine kinase NGF receptor.pH-Dependent Cellular Internalization of Paramagnetic Nanoparticle.Accessible Synthetic Probes for Staining Actin inside Platelets and Megakaryocytes by Employing Lifeact Peptide.NANOGOLD decorated by pHLIP peptide: comparative force field study.A free-blockage controlled release system based on the hydrophobic/hydrophilic conversion of mesoporous silica nanopores.Poly(oligonucleotide).Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses.pH-Responsive single walled carbon nanotube dispersion for target specific release of doxorubicin to cancer cells.Preparation of pH-sensitive zwitterionic nano micelles and drug controlled release for enhancing cellular uptake.Nanocarriers with multi-locked DNA valves targeting intracellular tumor-related mRNAs for controlled drug release.Catalytic Upgrading of Ethanol to n-Butanol: Progress in Catalyst Development.Synthesis of Europium-Doped Fluorapatite Nanorods and Their Biomedical Applications in Drug Delivery.A Dual-Targeting Octaguanidine-Doxorubicin Conjugate Transporter for Inducing Caspase-Mediated Apoptosis on Folate-Expressing Cancer Cells.A lysosome-targeted drug delivery system based on sorbitol backbone towards efficient cancer therapy.Dual-cargo selectively controlled release based on a pH-responsive mesoporous silica system.Single-cell study of the extracellular matrix effect on cell growth by in situ imaging of gene expression.Molecularly precise self-assembly of theranostic nanoprobes within a single-molecular framework for in vivo tracking of tumor-specific chemotherapy† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c8sc01069b.
P2860
Q30362001-63C5E4ED-1DF6-40BA-B900-F5AD772AC856Q30401826-AF8E1DB9-262F-497F-AB71-593BC62393A2Q35566912-879ADD8A-57B1-4FE1-B803-D2F94A745462Q35633363-473210C8-C477-4BB5-BC40-9AD23AF32591Q35898462-30E291AE-B37E-4D1A-BE5F-4C10B6276F45Q35946329-A5F26BDE-D751-4435-878A-27EFB9132EA7Q36307519-DBD1F392-7D7B-4B79-A3AA-97F953CB3F23Q36388931-A7647FAE-D3E5-46BB-852E-2F339A6133E1Q36531166-8C18C411-33D0-4C93-AA18-CC1EA9F82D59Q37494007-8DEA8439-6F50-41CE-A605-DF753B99CEA5Q37638621-C6E71FA7-A7EF-48E1-9437-EDB4F3182239Q38256244-2A0C918E-F5C9-4EA0-AFBB-7038206FBB18Q38271137-B29E1CA7-3874-44D7-A5E1-10451E9107E6Q38272165-0B5BB216-46F4-4A3D-A6E3-4A0ECBC79A92Q38639877-9EF230CE-C08C-4B99-ABC8-8ACC1479A1F9Q38765697-9075C28F-2426-46BE-8ADC-F59910CD6193Q38780297-AB9C1973-DDB1-4742-8EFE-F59E242257B6Q38784294-C09775EA-B27A-40B6-A467-C4D3FB95C4CCQ38796959-38FBD655-C08D-4A81-9DA4-63FDEB5ECE42Q38827516-3D197A72-39AE-46FC-8F95-D70E5D0E2A0AQ38852443-35B01B13-6EBB-41A3-96D2-2BA1A7FC89D7Q38913096-94548560-8DC3-400F-BB61-717494086ADFQ38958959-E2F9651C-FD84-4C4A-8D82-B451DCE17D42Q39043167-E41EB9A8-16B2-4B60-8C01-B31F4E6FE228Q40785813-6AE3CC50-2449-46CF-93E3-E89D4298C850Q40848535-BD03E01C-DB7B-4397-AB8C-DA58DF4711E4Q41027474-18C7EF3A-2F86-4254-9B9F-62301436845AQ41600610-4AA38EA6-01E8-4D9F-BAB3-405A681F27FDQ41963210-327D487B-F4A3-4C26-9F04-80066DD957C8Q42376109-6B0D927F-8E62-4EAB-A91C-284E37A8DBB1Q42795760-0C184CC3-5863-4D7B-8CD6-1569C85FF920Q42814967-AA29B9EA-AF8E-4B16-A829-57456E4A50EFQ47392365-F5C4A5E6-06FA-4B43-A411-651DC37FD219Q47953771-D747DC28-BCC3-47EE-AFB4-0CAC74F5B0A1Q48556418-9E223186-A6EA-414A-B9AD-71C097329790Q50248110-67A64D48-4393-4CE9-8C55-F201BB727B19Q53031862-C1865BCE-CB29-419A-BF27-E4BF718CF8FBQ53364442-4FF98373-AD3E-4966-8B9A-34D8F17DE61CQ53427859-414B7460-159B-4A7F-85B7-5A35A8F35A08Q55259044-65B58949-363F-4F72-A434-801F964530FC
P2860
A controlled-release nanocarrier with extracellular pH value driven tumor targeting and translocation for drug delivery.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A controlled-release nanocarri ...... anslocation for drug delivery.
@en
A controlled-release nanocarri ...... anslocation for drug delivery.
@nl
type
label
A controlled-release nanocarri ...... anslocation for drug delivery.
@en
A controlled-release nanocarri ...... anslocation for drug delivery.
@nl
prefLabel
A controlled-release nanocarri ...... anslocation for drug delivery.
@en
A controlled-release nanocarri ...... anslocation for drug delivery.
@nl
P2093
P2860
P356
P1476
A controlled-release nanocarri ...... anslocation for drug delivery.
@en
P2093
Hongmin Meng
Michael J Donovan
Mingxu You
Nannan Wang
Weihong Tan
Xiaobing Zhang
Zilong Zhao
P2860
P304
P356
10.1002/ANIE.201302557
P407
P577
2013-06-11T00:00:00Z